Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2021 ∙ Ciapponi, Agustín Bardach, Ariel Mazzoni, Agustina Alconada, Tomás Steven Anderson, A. Argento, Fernando J. Ballivian, Jamile Bok, Karin Comandé, Daniel Erbelding, Emily Goucher, Erin Kampmann, Beate Karron, Ruth Munoz, Flor M. Carolina Palermo, María P. K. Parker, Edward Rodriguez Cairoli, Federico Santa María, Victoria Stergachis, Andy S. Voss, Gerald Xiong, Xu Zamora, Natalia Zaraa, Sabra Berrueta, Mabel Buekens, Pierre M.

Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review

  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2021 ∙ Wan Ismail, W. R. Abdul Majid, M. Sh Li, H. Y. Madrim, M. F. Abdul Rahim, S. Sh S. Jeffree, M. S. Azhar, Z. I. Ghazi, H. F. Hassan, M. R.

Safety of dengue vaccine (CYD-TDV) in Asia: a systematic review

  • South-East Asia
  • Children
  • Adolescents
  • Adults
  • Dengue
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Desalermos, A. Pimienta, M. Kalligeros, M. Shehadeh, F. Diamantopoulos, L. Karamanolis, G. Caldera, F. Farraye, F. A.

Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis

  • Adults
  • Hepatitis B
  • Influenza
  • Herpes zoster
  • Pneumococcal disease
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Juvet, L. K. Robertson, A. H. Laake, I. Mjaaland, S. Trogstad, L.

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews

  • All age groups
  • Influenza
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Bandell, A. Ambrose, C. S. Maniaci, J. Wojtczak, H.

Safety of live attenuated influenza vaccine (LAIV) in children and adults with asthma: a systematic literature review and narrative synthesis

  • Children
  • Adolescents
  • Adults
  • Influenza
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Chen, M. Yuan, Y. Zhou, Y. Deng, Z. Zhao, J. Feng, F. Zou, H. Sun, C.

Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Lv, M. Luo, X. Shen, Q. Lei, R. Liu, X. Liu, E. Li, Q. Chen, Y.

Safety, immunogenicity, and efficacy of COVID-19 vaccines in children and adolescents: A systematic review

  • Children
  • Adolescents
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Rogliani, P. Chetta, A. Cazzola, M. Calzetta, L.

SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Sung, K. Y. Chang, T. E. Wang, Y. P. Lin, C. C. Chang, C. Y. Hou, M. C. Lu, C. L.

SARS-CoV-2 vaccination in patients with inflammatory bowel disease: systemic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Abid, M. A. Abid, M. B.

SARS-CoV-2 vaccine response in CAR T-cell therapy recipients: A systematic review and preliminary observations

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...